Pedro Gascón

4.0k total citations
60 papers, 3.2k citations indexed

About

Pedro Gascón is a scholar working on Oncology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Pedro Gascón has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in Pedro Gascón's work include Neuropeptides and Animal Physiology (17 papers), Receptor Mechanisms and Signaling (10 papers) and Cancer, Stress, Anesthesia, and Immune Response (8 papers). Pedro Gascón is often cited by papers focused on Neuropeptides and Animal Physiology (17 papers), Receptor Mechanisms and Signaling (10 papers) and Cancer, Stress, Anesthesia, and Immune Response (8 papers). Pedro Gascón collaborates with scholars based in United States, Spain and South Korea. Pedro Gascón's co-authors include Susana García‐Recio, Pranela Rameshwar, Neal S. Young, Vanessa Almendro, Elisabet Ametller, Giancarlo Ghiselli, Nicholas Zoumbos, Julie Y. Djeu, Ernst J. Schaefer and Jing Qian and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Pedro Gascón

60 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pedro Gascón 1.1k 694 679 570 529 60 3.2k
Keiichi Enjyoji 1.1k 1.0× 413 0.6× 159 0.2× 507 0.9× 1.1k 2.1× 80 4.9k
Martha Kirby 1.9k 1.8× 800 1.2× 256 0.4× 587 1.0× 2.1k 4.0× 83 5.8k
Antonio Porcellini 2.2k 2.1× 723 1.0× 483 0.7× 343 0.6× 975 1.8× 152 4.6k
Yoshihiro Fujimori 1.1k 1.0× 429 0.6× 234 0.3× 593 1.0× 805 1.5× 99 3.1k
Sawsan Youssef 1.4k 1.3× 853 1.2× 330 0.5× 192 0.3× 2.4k 4.6× 46 5.2k
Ho Jin Kim 654 0.6× 569 0.8× 254 0.4× 222 0.4× 914 1.7× 172 5.9k
Grace Ku 929 0.9× 788 1.1× 220 0.3× 325 0.6× 387 0.7× 56 2.8k
Yvonne Reiss 2.1k 2.0× 845 1.2× 270 0.4× 217 0.4× 1.3k 2.4× 43 4.4k
Jian-Guo Geng 1.7k 1.6× 550 0.8× 609 0.9× 475 0.8× 1.0k 1.9× 51 3.9k
Phillip L. Campbell 934 0.9× 416 0.6× 157 0.2× 190 0.3× 647 1.2× 52 2.5k

Countries citing papers authored by Pedro Gascón

Since Specialization
Citations

This map shows the geographic impact of Pedro Gascón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Gascón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Gascón more than expected).

Fields of papers citing papers by Pedro Gascón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Gascón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Gascón. The network helps show where Pedro Gascón may publish in the future.

Co-authorship network of co-authors of Pedro Gascón

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Gascón. A scholar is included among the top collaborators of Pedro Gascón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Gascón. Pedro Gascón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández‐Nogueira, Patricia, Gemma Fuster, Patricia Jáuregui, et al.. (2018). Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer. Cancer Letters. 424. 70–83. 43 indexed citations
2.
Erazo, Tatiana, Mar Lorente, Patricia Fernández‐Nogueira, et al.. (2015). The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase. Clinical Cancer Research. 22(10). 2508–2519. 59 indexed citations
3.
Wu, Min-Zu, Su-Feng Chen, Shin Nieh, et al.. (2015). Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis. Cancer Research. 75(18). 3912–3924. 106 indexed citations
4.
García‐Recio, Susana, Eva M. Pastor‐Arroyo, Mercedes Marín‐Aguilera, Vanessa Almendro, & Pedro Gascón. (2015). The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation. PLoS ONE. 10(6). e0129661–e0129661. 20 indexed citations
5.
García‐Recio, Susana, Gemma Fuster, Patricia Fernández‐Nogueira, et al.. (2013). Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer. Cancer Research. 73(21). 6424–6434. 76 indexed citations
6.
Marín‐Aguilera, Mercedes, Jordi Codony‐Servat, Susana G. Kalko, et al.. (2011). Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 11(2). 329–339. 86 indexed citations
7.
Mayordomo, Cristina, Susana García‐Recio, Elisabet Ametller, et al.. (2011). Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2. Journal of Cellular Physiology. 227(4). 1358–1366. 69 indexed citations
8.
Ametller, Elisabet, Susana García‐Recio, Gerard Callejo, et al.. (2011). Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death. Cancer Biology & Therapy. 11(1). 4–13. 9 indexed citations
9.
Almendro, Vanessa, Susana García‐Recio, & Pedro Gascón. (2010). Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors. Current Drug Targets. 11(9). 1169–1180. 57 indexed citations
10.
Ametller, Elisabet, Susana García‐Recio, Domiziana Costamagna, et al.. (2010). Tumor promoting effects of CD95 signaling in chemoresistant cells. Molecular Cancer. 9(1). 161–161. 18 indexed citations
11.
Almendro, Vanessa, Elisabet Ametller, Susana García‐Recio, et al.. (2009). The Role of MMP7 and Its Cross-Talk with the FAS/FASL System during the Acquisition of Chemoresistance to Oxaliplatin. PLoS ONE. 4(3). e4728–e4728. 67 indexed citations
12.
Montagut, Clara, Maribel Mármol, Jaume Ordï, et al.. (2003). Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus. Gynecologic Oncology. 90(2). 458–461. 19 indexed citations
13.
Rameshwar, Pranela, et al.. (2003). Defect in the lymphoid compartment might account for CD8+-mediated effects in the pathophysiology of pure red cell aplasia. Clinical Immunology. 108(3). 248–256. 4 indexed citations
14.
Bandari, Persis, Jing Qian, Ghassan Yehia, et al.. (2003). Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P. Regulatory Peptides. 111(1-3). 169–178. 47 indexed citations
15.
Qian, Jing, Ghassan Yehia, Carlos A. Molina, et al.. (2001). Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5′-Monophosphate Response Elements in Its Expression by IL-1 and Stem Cell Factor. The Journal of Immunology. 166(4). 2553–2561. 45 indexed citations
16.
17.
18.
Rameshwar, Pranela, et al.. (1998). Systemic transforming growth factor-beta in patients with bone marrow fibrosis—pathophysiological implications. American Journal of Hematology. 59(2). 133–142. 47 indexed citations
19.
Gascón, Pedro, et al.. (1993). Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. The American Journal of Medicine. 94(1). 41–48. 21 indexed citations
20.
Platanias, Leonidas C., Pedro Gascón, Leonard Bielory, et al.. (1987). Lymphocyte phenotype and lymphokines following anti‐thymocyte globulin therapy in patients with aplastic anaemia. British Journal of Haematology. 66(4). 437–443. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiichi Enjyoji Breakdown of academic impact, for papers by Martha Kirby Breakdown of academic impact, for papers by Antonio Porcellini Breakdown of academic impact, for papers by Yoshihiro Fujimori Breakdown of academic impact, for papers by Sawsan Youssef Breakdown of academic impact, for papers by Ho Jin Kim Breakdown of academic impact, for papers by Grace Ku Breakdown of academic impact, for papers by Yvonne Reiss Breakdown of academic impact, for papers by Jian-Guo Geng Breakdown of academic impact, for papers by Phillip L. Campbell
Rankless by CCL
2026